Retatrutide — lab test, July 2026
COA COA-2026-CYMA92 matches ILS Laboratories's public record. So this test doesn't rest on our review alone — the lab confirms it too.
5NS66Q53Test results
Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 20 mg · Lab measured 20.82 mg
104% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 5.2 mg using the measured mass, against 5 mg on the label — 4% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | COA-2026-CYMA92 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | ILS Laboratories's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Retatrutide, performed by ILS Laboratories on July 15, 2026. Reported purity: 99.57%. Net content: 20.82 mg against 20 mg labeled (104% of label). Batch RC-260701-002. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion